Studies are conducted to define the mechanisms involved in tumor growth and metastasis and to develop new animal models of human cancers. We have found that a basement membrane extract (Matrigel) when premixed with human tumor cells (which do not grow well in mice) promotes their incidence and growth. We have been able to culture new highly differentiated human tumor cell lines from the tumors grown in mice including certain colon cell lines. Laminin, a major basement membrane component, has been found to promote the malignant phenotype. Laminin adherent cells are more malignant than either the non-adherent cells or the parental cells. Various biologically active laminin-derived synthetic peptides have been identified. One, YIGSR (tyr-ile-gly-ser-arg) reduces tumor growth, metastases, and angiogenesis whereas IKVAV increases these activities. Another peptide LQVQLSIR increases metastases but a mechanism has not yet been defined. Our goal is to define the molecular mechanisms involved in tumor growth and metastases. Our approach is to (1) select for and isolate highly malignant cells, (2) define their cellular laminin receptors, (3) identify additional sequences on laminin which promote or reduce the malignant phenotype, (4) identify genes involved in malignancy and (5) define molecules in bone responsible for prostate and breast cancerorgan-specific metastases. We work with several models including B16F10 melanoma cells, breast, prostate and salivary gland tumor cells. We hope to define regulatory events involved in metastases and develop therapeutic and diagnostic reagents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Intramural Research (Z01)
Project #
1Z01DE000482-10
Application #
6163411
Study Section
Special Emphasis Panel (CDBR)
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
National Institute of Dental & Craniofacial Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Campo McKnight, Dianalee A; Sosnoski, Donna M; Koblinski, Jennifer E et al. (2006) Roles of osteonectin in the migration of breast cancer cells into bone. J Cell Biochem 97:288-302
Koblinski, Jennifer E; Kaplan-Singer, Benjamin R; VanOsdol, Sherilyn J et al. (2005) Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res 65:7370-7
Huh, Jung-Im; Calvo, Alfonso; Stafford, Jeffrey et al. (2005) Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene 24:790-800
Hibino, Suguru; Shibuya, Masahiko; Engbring, Jean A et al. (2004) Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res 64:4810-6
Bos, T J; Cohn, S L; Kleinman, H K et al. (2004) International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. Matrix Biol 23:63-9
Elkin, Michael; Orgel, Adam; Kleinman, Hynda K (2004) An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst 96:875-8
Lugassy, Claire; Kleinman, Hynda K; Engbring, Jean A et al. (2004) Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. Am J Pathol 164:1191-8
Munshi, Hidayatullah G; Wu, Yi I; Mukhopadhyay, Subhendu et al. (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 279:39042-50
Elkin, Michael; Cohen, Irit; Zcharia, Eyal et al. (2003) Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res 63:8821-6
Cha, Hee-Jae; Jeong, Moon-Jin; Kleinman, Hynda K (2003) Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95:1674-80

Showing the most recent 10 out of 12 publications